Artificial Joints; Prosthetic/Prosthesis Implanted to Replace Diseased or Damaged Joint



Artificial joints are a prosthesis or prosthetic joint, made of metal, ceramic, or plastic, which is implanted to replace a diseased or damaged natural joint. Joints can be damaged by various causes, arthritis, injuries, and other diseases. Replacement arthroplasty, also known as joint replacement surgery, is an invasive procedure of cosmetic orthopedic surgery where an arthritic or degenerative joint surface is replaced by artificial joints.

This operation involves the surgical reconstruction of a joint and its surrounding tissues. When serious joint pain or stiffness is not relieved by more-restful non-surgical therapies, joint replacement is usually considered as an effective treatment. Although replacement arthroplasty is more invasive than other joint reinstalls, it can often be performed in less time and at a lower cost than other reconstructive surgeries.

Other factors that can cause arthroplasty to be recommended include prior damage to the joint, the presence of osteoarthritis or other autoimmune diseases, and progressive bone age. These conditions are sometimes associated with arthritis, which makes arthroplasty an ideal treatment for them. Other factors that can make this treatment desirable include a bony growth on the joint, or a joint deformation that does not respond to traditional anti-inflammatory treatments.

Patients with severe joint inflammation can also benefit from artificial joints because their pain has progressed to the point at which conventional treatments have been ineffective. Moreover, some patients find that their arthritic condition makes healing difficult because of decreased range of motion. Moreover, osteoarthritis is the most prevalent musculoskeletal disease, which affects geriatric population. Thus, with the growing geriatric population, demand for artificial joints is also increasing with a rapid pace.

According to the U.S. Census Bureau, the nation's 65-and-older population is projected to reach 83.7 million in the year 2050, almost double in size from the 2012 level of 43.1 million. There were 54 million U.S. residents 65 years and older in the 2019. However, high cost of artificial joints is expected to hamper the demand for artificial joints.

 

artificial joints, prosthetic joints, prosthesis joints, damaged joint, healthcare, joint inflammation, tissues, surgical reconstruction, autoimmune diseases

Comments

Post a Comment

Popular posts from this blog

Increasing Consumption and Production of Fertilizers to Upsurge the Growth of the Agrochemicals Market

Image
  Agrochemical products are those chemicals that are used to increase the production of an agricultural environment. Agrochemical chemicals typically include pesticides, fertilizers, lime precursors, acidizing and alkalizing agents (all of which are designed to alter the normal pH level of the soil), lime stabilizers, and other nutrients that are required for plant growth. These chemicals are widely used by farmers and are crucial to the functioning of modern agriculture. The use of these chemicals presents a number of concerns both from the perspective of the environment and the human body. The increasing need for improving crop production due to the growing concern of food security and lack of arable land is fueling the growth of agrochemicals market . Growing advancement in technology is raising adoption of advanced and sustainable farming practices which is again propelling the growth of the market. The increasing population coupled with the growing usage of fertilizers around th
Read more

High Prevalence of Cancer and R&D in Anti-Cd39 Antibodies to Augment Growth of Anti-body Coupled T Receptor Therapy Market

Image
  Antibody-Coupled T cell Receptor (ACTR) is an autologous engineered T cell therapy that combines the Fc receptor, CD16, with endogenous T cell signaling and costimulatory domains. It is combined with tumor-targeting antibodies to exert potent anti-tumor immune responses and eliminate cancerous cells. ACRT has demonstrated potential in the treatment of multiple myeloma and HER2+ advanced cancers. Market Dynamics R&D in anti-CD39 antibodies is expected to propel growth of the Anti-body Coupled T Receptor Therapy Market . For instance, in December 2020, Arcus Biosciences, Inc. expanded its existing partnership with WuXi Biologics, a developer of biologics technology platforms, for R&D in anti-CD39 antibodies using WuXi Bio’s proprietary technology. Moreover, high prevalence of cancer is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 canc
Read more

Increasing Prevalence of Muscular Dystrophy to Augment the Muscular Dystrophy Treatment Market Growth

Image
  Muscular dystrophy is a common disease that causes muscles to become weaker and unable to continue to develop properly. Because it often affects young children as well as adults, it can be difficult to detect. However, once symptoms are noticed, steps must be taken to prevent the disease. There are many treatment options available for muscular dystrophy. The severity of the disease will determine what type of treatment is best for your situation. Muscular dystrophy treatment involves breathing aids, therapy, surgery, or medication, which may help maintain function, but life span is often shortened. Market Dynamics: Increasing prevalence or incidence of muscular dystrophy, especially in the North America, is expected to propel the growth of the muscular dystrophy treatment market . For instance, one in 3,500 male babies born worldwide are affected with Duchenne muscular dystrophy (DMD), according to the National Organization for Rare Disorders. Moreover, in 2019, around 349 new ca
Read more